Review
doi: 10.1007/s11154-019-09531-x.Definition and diagnosis of aggressive pituitary tumors
Leandro Kasuki 1 2 3, Gérald Raverot 4 5 6 7
Affiliations
- PMID:31808044
- DOI: 10.1007/s11154-019-09531-x
Item in Clipboard
Review
Definition and diagnosis of aggressive pituitary tumors
Leandro Kasuki et al. Rev Endocr Metab Disord.2020 Jun.
Display options
Format
Display options
Format
Abstract
Pituitary adenomas are considered benign tumors, but approximately 10% of them can have an aggressive behavior and more rarely (0.2%) can present metastasis, being classified as pituitary carcinomas. Aggressive adenomas are generally large and invasive tumors that present unusually rapid growth and/or that grow irrespective of conventional treatment with surgery, medical therapy and radiotherapy. Nevertheless, large tumors, as well as invasive tumors are not always aggressive, with this definition being possible only after clinical follow-up of these tumors, with growth rate and response to therapies being key points to its diagnosis. The correct identification and diagnosis of aggressive adenomas is of great importance as they are associated with great morbidity and increased mortality.
Keywords: Aggressive tumors; Invasive tumors; Pituitary adenomas; Pituitary carcinoma.
Similar articles
- The epidemiology of aggressive pituitary tumors (and its challenges).Dekkers OM, Karavitaki N, Pereira AM.Dekkers OM, et al.Rev Endocr Metab Disord. 2020 Jun;21(2):209-212. doi: 10.1007/s11154-020-09556-7.Rev Endocr Metab Disord. 2020.PMID:32361816Free PMC article.Review.
- Aggressive Pituitary Adenomas and Carcinomas.Ilie MD, Jouanneau E, Raverot G.Ilie MD, et al.Endocrinol Metab Clin North Am. 2020 Sep;49(3):505-515. doi: 10.1016/j.ecl.2020.05.008. Epub 2020 Jul 8.Endocrinol Metab Clin North Am. 2020.PMID:32741485Review.
- Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician's questions.Trouillas J, Jaffrain-Rea ML, Vasiljevic A, Dekkers O, Popovic V, Wierinckx A, McCormack A, Petersenn S, Burman P, Raverot G, Villa C.Trouillas J, et al.Rev Endocr Metab Disord. 2020 Jun;21(2):243-251. doi: 10.1007/s11154-020-09562-9.Rev Endocr Metab Disord. 2020.PMID:32504268Review.
- The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.Dai C, Liang S, Sun B, Kang J.Dai C, et al.Front Endocrinol (Lausanne). 2020 Dec 11;11:608422. doi: 10.3389/fendo.2020.608422. eCollection 2020.Front Endocrinol (Lausanne). 2020.PMID:33362722Free PMC article.Review.
- Early recognition of aggressive pituitary adenomas: a single-centre experience.Ceccato F, Regazzo D, Barbot M, Denaro L, Emanuelli E, Borsetto D, Rolma G, Alessio L, Gardiman MP, Lombardi G, Albiger N, D'Avella D, Scaroni C.Ceccato F, et al.Acta Neurochir (Wien). 2018 Jan;160(1):49-55. doi: 10.1007/s00701-017-3396-5. Epub 2017 Nov 23.Acta Neurochir (Wien). 2018.PMID:29170844
Cited by
- The expression ofVDACs andBcl2 family genes in pituitary adenomas: clinical correlations and postsurgical outcomes.Facundo AN, Magalhães M, Nascimento GC, Azulay RS, Santos RM, Freitas LA, Nascimento A, Rodrigues VP, Santos WC, Beckman A, Abreu J, Silva RP, Carneiro EL, Oliveira Neto CP, Gil da Costa RM, Corcoy R, Mato E, Faria MS.Facundo AN, et al.Front Endocrinol (Lausanne). 2024 Oct 10;15:1481050. doi: 10.3389/fendo.2024.1481050. eCollection 2024.Front Endocrinol (Lausanne). 2024.PMID:39449743Free PMC article.
- High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors.Zhao W, Jiang X, Weisenthal K, Ma J, Botticelli EM, Zhou Y, Hedley-Whyte ET, Wang B, Swearingen B, Soberman RJ, Klibanski A, Zhang X.Zhao W, et al.Front Oncol. 2022 May 13;12:875122. doi: 10.3389/fonc.2022.875122. eCollection 2022.Front Oncol. 2022.PMID:35646715Free PMC article.
- UPDATES IN AGGRESSIVE PITUITARY TUMORS.Burcea I, Poiana C.Burcea I, et al.Acta Endocrinol (Buchar). 2020 Apr-Jun;16(2):267-273. doi: 10.4183/aeb.2020.267.Acta Endocrinol (Buchar). 2020.PMID:33029249Free PMC article.
- Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers.Shen Y, Zhao N, Zhao N, Hu X, He X, Xu Y, Chen J, Chen W, Liu X, Zhou Z, Cao D, Xu X.Shen Y, et al.Int J Mol Sci. 2022 Sep 16;23(18):10823. doi: 10.3390/ijms231810823.Int J Mol Sci. 2022.PMID:36142734Free PMC article.Review.
- Plurihormonal PIT-1-Positive Pituitary Adenomas: A Systematic Review and Single-Center Series.Andrews JP, Joshi RS, Pereira MP, Oh T, Haddad AF, Pereira KM, Osorio RC, Donohue KC, Peeran Z, Sudhir S, Jain S, Beniwal A, Chopra AS, Sandhu NS, Tihan T, Blevins L, Aghi MK.Andrews JP, et al.World Neurosurg. 2021 Jul;151:e185-e191. doi: 10.1016/j.wneu.2021.04.003. Epub 2021 Apr 20.World Neurosurg. 2021.PMID:33862299Free PMC article.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Medical